Life Transitions

An analysis of data from the China Kadoorie Biobank study suggests cumulative exposure to estrogen was associated with stroke risk in postmenopausal women.

A recent study analyzed the effect artificially sweetened beverages have on urinary incontinence in women.

Rebecca Thurston, PhD, sits down to discuss her research presented at the NAMS Annual Meeting on vasomotor symptoms and cardiovascular health.

Rebecca Thurston, PhD, sits down to discuss the latest news from the North American Menopause Society Annual Meeting.

Research in Menopause connects history of physical/sexual abuse, financial instability with worse menopausal symptoms and overall wellbeing at midlife.

History of migraine may be associated with poor sleep in premenopausal and perimenopausal women, according to research presented at the North American Menopause Society Annual Meeting.

Traumatic experiences are associated with lower levels of sex hormones in midlife women, especially those with short sleep, according to research presented at the North American Menopause Society Annual Meeting.

A presentation at the North American Menopause Society Annual Meeting outlined the approval status and effectiveness of various pharmacologic treatments of vasomotor symptoms.

In a presentation at the North American Menopause Society Annual Meeting, a study found that women may be more inclined to gain weight during the menopause transition.

Women with diabetes are more susceptible to early menopause, according to a study presented at the North American Menopause Society Annual Meeting.

Hormone therapy was linked as a potential preventative treatment for adhesive capsulitis in menopausal women, according to a study presented at the North American Menopause Society Annual Meeting.

In a presentation at the North American Menopause Society Annual Meeting, investigators found these signs of menopause are 2 very separate symptoms and have different effects on stress and depression in menopausal women.

More women are using medical cannabis for menopause-related symptoms, according to research recently published in Menopause.

The Women’s Preventive Services Initiative (WPSI) has released a new clinical guideline outlining their recommendations for preventing obesity among women in midlife.

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Women with the highest PTSD symptoms level experienced significantly worse rates of change regarding learning and working memory.

New research suggests cumulative exposure to PFAS could increase risk of incident hypertension by 71% among midlife women.

New research from a team of investigators in Europe suggests hormonal changes during menopause could explain up to 10% of the increase in LDL-C associated with the transition to menopause among aging women

An analysis of data from a Cleveland Clinic database indicates calcium supplementation in older adults with aortic stenosis was linked to an increased risk of mortality and worsening aortic stenosis.

Data from a cohort of 5000 patients indicates that NSAID use may negatively affect clodronate therapy in older women.

Data from an analysis of a SWAN substudy suggests increased exposure to PFAS was linked to an increased risk of incident diabetes during midlife among women.

Women with laparoscopically confirmed endometriosis are at significantly higher risk for early natural menopause (ENM), and this risk was greater for nulliparous women and women who never reported using oral contraceptives, according to a study in JAMA Network Open.

A recent study found overweight status in midlife, compared to normal body mass index, was linked to a higher burden of morbidity and greater proportion of life lived with morbidity.

Astellas announced positive data from its study investigating the long-term safety of fezolinetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

More than half of postmenopausal women experience female pattern hair loss, according to a cross-sectional study in the journal Menopause.

Risk assessment, lifestyle counseling, adverse effects, and medication management.

According to a recent study, women who experience stable menstrual cycles during the menopause transition have a significantly higher cardiovascular disease (CVD) risk later in life than those who have a late increase in cycle length.

Midlife women with early-stage vision impairment are significantly more likely to develop depressive symptoms, according to a study in the journal Menopause, which used data from the Michigan site of the Study of Women’s Health Across the Nation (SWAN).

A more standardized approach to menopause preparedness, including educating both patients and providers, is needed to improve care and quality of life for individuals during and after menopause, according to a study in the journal Menopause.

Physical inactivity can exacerbate BMD decline and increase fracture risk.